Doxepin Hydrochloride Patent Expiration

Doxepin Hydrochloride is Used for treating insomnia. It was first introduced by Pfizer Laboratories Div Pfizer Inc in its drug Sinequan on Approved Prior to Jan 1, 1982. Other drugs containing Doxepin Hydrochloride are Silenor, Zonalon, Doxepin Hydrochloride. 40 different companies have introduced drugs containing Doxepin Hydrochloride.


Doxepin Hydrochloride Patents

Given below is the list of patents protecting Doxepin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Silenor US10238620 Methods of using low-dose doxepin for the improvement of sleep May 18, 2027 Currax
Silenor US10548871 Low-dose doxepin formulations and methods of making and using the same Apr 11, 2028 Currax
Silenor US10653660 Methods of improving the pharmacokinetics of doxepin Jul 20, 2027 Currax
Silenor US10653662 Methods of using low-dose doxepin for the improvement of sleep May 18, 2027 Currax
Silenor US11096920 Low-dose doxepin formulations and methods of making and using the same Apr 11, 2028 Currax
Silenor US11110074 Methods of improving the pharmacokinetics of doxepin Jul 20, 2027 Currax
Silenor US11234954 Low-dose doxepin for treatment of sleep disorders in elderly patients Jan 18, 2028 Currax
Silenor US5502047 Treatment for insomnia Mar 26, 2013

(Expired)

Currax
Silenor US5585115 Pharmaceutical excipient having improved compressability Jan 09, 2015

(Expired)

Currax
Silenor US5725884 Pharmaceutical excipient having improved compressibility Jan 09, 2015

(Expired)

Currax
Silenor US5866166 Pharmaceutical excipient having improved compressibility Jan 09, 2015

(Expired)

Currax
Silenor US5948438 Pharmaceutical formulations having improved disintegration and/or absorptivity Jan 09, 2015

(Expired)

Currax
Silenor US6103219 Pharmaceutical excipient having improved compressibility Jan 09, 2015

(Expired)

Currax
Silenor US6211229 Treatment of transient and short term insomnia Feb 17, 2020

(Expired)

Currax
Silenor US6217909 Pharmaceutical excipient having improved compressibility Jan 09, 2015

(Expired)

Currax
Silenor US7915307 Methods of improving the pharmacokinetics of doxepin Aug 24, 2027 Currax
Silenor US8513299 Methods of using low-dose doxepin for the improvement of sleep Sep 07, 2030 Currax
Silenor US9107898 Methods of using low-dose doxepin for the improvement of sleep May 01, 2028 Currax
Silenor US9486437 Methods of using low-dose doxepin for the improvement of sleep May 18, 2027 Currax
Silenor US9532971 Low-dose doxepin formulations and methods of making and using the same Jun 01, 2029 Currax
Silenor US9572814 Methods of improving the pharmacokinetics of doxepin Jul 20, 2027 Currax
Silenor US9861607 Methods of using low-dose doxepin for the improvement of sleep May 18, 2027 Currax
Silenor US9907780 Low-dose doxepin formulations and methods of making and using the same Apr 11, 2028 Currax


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Doxepin Hydrochloride Generics

Several generic applications have been filed for Doxepin Hydrochloride. The first generic version for Doxepin Hydrochloride was by Mylan Pharmaceuticals Inc and was approved on May 13, 1986. And the latest generic version is by Ajanta Pharma Ltd and was approved on Jul 1, 2024.

Given below is the list of companies who have filed for Doxepin Hydrochloride generic.


1. AMNEAL PHARMS CO

Amneal Pharmaceuticals Co Gmbh has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Prescription ORAL AB Jun 28, 2017
EQ 10MG BASE capsule Prescription ORAL AB Jun 28, 2017
EQ 25MG BASE capsule Prescription ORAL AB Jun 28, 2017
EQ 50MG BASE capsule Prescription ORAL AB Jun 28, 2017
EQ 75MG BASE capsule Prescription ORAL AB Jun 28, 2017


2. WATSON LABS TEVA

Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Discontinued ORAL N/A Mar 29, 1991


3. PUREPAC PHARM

Purepac Pharmaceutical Co has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Purepac Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Discontinued ORAL N/A Sep 8, 1988
EQ 150MG BASE capsule Discontinued ORAL N/A Sep 8, 1988
EQ 75MG BASE capsule Discontinued ORAL N/A Sep 8, 1988
EQ 50MG BASE capsule Discontinued ORAL N/A Dec 28, 1990
EQ 25MG BASE capsule Discontinued ORAL N/A Dec 28, 1990
EQ 10MG BASE capsule Discontinued ORAL N/A Dec 28, 1990


4. MICRO LABS

Micro Labs Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Micro Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Prescription ORAL AB Jun 27, 2023
EQ 10MG BASE capsule Prescription ORAL AB Jun 27, 2023
EQ 25MG BASE capsule Prescription ORAL AB Jun 27, 2023
EQ 50MG BASE capsule Prescription ORAL AB Jun 27, 2023
EQ 75MG BASE capsule Prescription ORAL AB Jun 27, 2023


5. AMNEAL

Amneal Pharmaceuticals Llc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% cream Prescription TOPICAL AB Aug 16, 2023


6. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 7 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Prescription ORAL AB Sep 13, 2019
EQ 25MG BASE capsule Prescription ORAL AB Sep 13, 2019
EQ 50MG BASE capsule Prescription ORAL AB Sep 13, 2019
EQ 100MG BASE capsule Prescription ORAL AB Sep 13, 2019
EQ 75MG BASE capsule Prescription ORAL AB Sep 13, 2019
EQ 6MG BASE tablet Prescription ORAL AB Jul 1, 2024
EQ 3MG BASE tablet Prescription ORAL AB Jul 1, 2024


7. LEADING

Leading Pharma Llc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Leading.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE capsule Prescription ORAL AB Mar 1, 2021


8. QUANTUM PHARMICS

Quantum Pharmics Ltd has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Quantum Pharmics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Discontinued ORAL N/A Sep 29, 1987
EQ 75MG BASE capsule Discontinued ORAL N/A Sep 29, 1987
EQ 25MG BASE capsule Discontinued ORAL N/A Sep 29, 1987
EQ 50MG BASE capsule Discontinued ORAL N/A Sep 29, 1987
EQ 150MG BASE capsule Discontinued ORAL N/A Mar 15, 1989
EQ 100MG BASE capsule Discontinued ORAL N/A Mar 15, 1989


9. TEVA PHARMS

Teva Pharmaceuticals Development Inc has filed for 2 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE/ML concentrate Discontinued ORAL N/A Nov 9, 1987
5% cream Prescription TOPICAL AB Feb 17, 2023


10. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Prescription ORAL AB May 13, 1986
EQ 25MG BASE

(reference standard)

capsule Prescription ORAL AB May 13, 1986
EQ 100MG BASE

(reference standard)

capsule Prescription ORAL AB May 13, 1986
EQ 75MG BASE capsule Prescription ORAL AB May 13, 1986
EQ 50MG BASE capsule Prescription ORAL AB May 13, 1986


11. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Prescription ORAL AB Apr 21, 2021
EQ 75MG BASE capsule Prescription ORAL AB Apr 21, 2021
EQ 100MG BASE capsule Prescription ORAL AB Apr 21, 2021
EQ 50MG BASE capsule Prescription ORAL AB Apr 21, 2021
EQ 25MG BASE capsule Prescription ORAL AB Apr 21, 2021


12. WATSON LABS

Watson Laboratories Inc has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE capsule Discontinued ORAL N/A Mar 29, 1991
EQ 50MG BASE capsule Discontinued ORAL N/A Apr 30, 1987
EQ 100MG BASE capsule Discontinued ORAL N/A Apr 30, 1987
EQ 10MG BASE capsule Discontinued ORAL N/A Mar 29, 1991
EQ 75MG BASE capsule Discontinued ORAL N/A Feb 9, 1988
EQ 150MG BASE capsule Discontinued ORAL N/A Feb 9, 1988


13. PHARM ASSOC

Pharmaceutical Assoc Inc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Pharm Assoc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE/ML concentrate Discontinued ORAL N/A Jan 15, 2004


14. ZYDUS LIFESCIENCES

Zydus Lifesciences Ltd has filed for 8 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE capsule Prescription ORAL AB Mar 21, 2023
EQ 100MG BASE capsule Prescription ORAL AB Mar 23, 2023
EQ 25MG BASE capsule Prescription ORAL AB Mar 23, 2023
EQ 10MG BASE capsule Prescription ORAL AB Mar 23, 2023
EQ 50MG BASE capsule Prescription ORAL AB Mar 23, 2023
EQ 75MG BASE capsule Prescription ORAL AB Mar 23, 2023
EQ 6MG BASE tablet Discontinued ORAL N/A Aug 16, 2023
EQ 3MG BASE tablet Discontinued ORAL N/A Aug 16, 2023


15. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE capsule Discontinued ORAL N/A Feb 18, 1988
EQ 75MG BASE capsule Discontinued ORAL N/A Feb 18, 1988
EQ 50MG BASE capsule Discontinued ORAL N/A Feb 18, 1988
EQ 100MG BASE capsule Discontinued ORAL N/A Feb 18, 1988


16. LANNETT CO INC

Lannett Co Inc has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE/ML

(reference standard)

concentrate Prescription ORAL N/A Dec 29, 1998
EQ 75MG BASE capsule Discontinued ORAL N/A Jul 24, 2020
EQ 25MG BASE capsule Discontinued ORAL N/A Jul 24, 2020
EQ 10MG BASE capsule Discontinued ORAL N/A Jul 24, 2020
EQ 100MG BASE capsule Discontinued ORAL N/A Jul 24, 2020
EQ 50MG BASE capsule Discontinued ORAL N/A Jul 24, 2020


17. RK PHARMA

Rk Pharma Inc has filed for 2 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Rk Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 3MG BASE tablet Prescription ORAL AB Jan 20, 2016
EQ 6MG BASE tablet Prescription ORAL AB Jan 20, 2016


18. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Prescription ORAL AB Mar 27, 2019
EQ 25MG BASE capsule Prescription ORAL AB Mar 27, 2019
EQ 10MG BASE capsule Prescription ORAL AB Mar 27, 2019
EQ 100MG BASE capsule Prescription ORAL AB Mar 27, 2019
EQ 75MG BASE capsule Prescription ORAL AB Mar 27, 2019


19. UNIQUE PHARM

Unique Pharmaceutical Laboratories has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Unique Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE capsule Prescription ORAL AB Aug 21, 2023
EQ 25MG BASE capsule Prescription ORAL AB Aug 21, 2023
EQ 50MG BASE capsule Prescription ORAL AB Aug 21, 2023
EQ 10MG BASE capsule Prescription ORAL AB Aug 21, 2023
EQ 100MG BASE capsule Prescription ORAL AB Aug 21, 2023


20. PHARMOBEDIENT CNSLTG

Pharmobedient Consulting has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Pharmobedient Cnsltg.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE/ML concentrate Discontinued ORAL N/A Jul 20, 1988


21. MANKIND PHARMA

Mankind Pharma Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Mankind Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Prescription ORAL AB Feb 9, 2022
EQ 100MG BASE capsule Prescription ORAL AB Feb 9, 2022
EQ 75MG BASE capsule Prescription ORAL AB Feb 9, 2022
EQ 10MG BASE capsule Prescription ORAL AB Feb 9, 2022
EQ 25MG BASE capsule Prescription ORAL AB Feb 9, 2022


22. EPIC PHARMA LLC

Epic Pharma Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE capsule Prescription ORAL AB Oct 16, 2020
EQ 10MG BASE capsule Prescription ORAL AB Oct 16, 2020
EQ 100MG BASE capsule Prescription ORAL AB Oct 16, 2020
EQ 75MG BASE capsule Prescription ORAL AB Mar 3, 2022
EQ 50MG BASE capsule Prescription ORAL AB Mar 3, 2022


23. CHEMISTRY HLTH

Chemistry And Health Fz Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Chemistry Hlth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE capsule Prescription ORAL AB Mar 9, 2021
EQ 100MG BASE capsule Prescription ORAL AB Mar 9, 2021
EQ 50MG BASE capsule Prescription ORAL AB Mar 9, 2021
EQ 25MG BASE capsule Prescription ORAL AB Mar 9, 2021
EQ 10MG BASE capsule Prescription ORAL AB Mar 9, 2021


24. MSN

Msn Laboratories Private Ltd has filed for 7 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Prescription ORAL AB Jun 24, 2022
EQ 10MG BASE capsule Prescription ORAL AB Jun 24, 2022
EQ 25MG BASE capsule Prescription ORAL AB Jun 24, 2022
EQ 75MG BASE capsule Prescription ORAL AB Jun 24, 2022
EQ 100MG BASE capsule Prescription ORAL AB Jun 24, 2022
EQ 6MG BASE tablet Prescription ORAL AB Apr 3, 2023
EQ 3MG BASE tablet Prescription ORAL AB Apr 3, 2023


25. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 2 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 3MG BASE tablet Prescription ORAL AB Jul 26, 2013
EQ 6MG BASE tablet Prescription ORAL AB Jul 26, 2013


26. ENDO OPERATIONS

Endo Operations Ltd has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Discontinued ORAL N/A Nov 9, 1987
EQ 10MG BASE capsule Discontinued ORAL N/A Nov 9, 1987
EQ 25MG BASE capsule Discontinued ORAL N/A Nov 9, 1987
EQ 50MG BASE capsule Discontinued ORAL N/A Nov 9, 1987
EQ 75MG BASE capsule Discontinued ORAL N/A Nov 9, 1987
EQ 150MG BASE

(reference standard)

capsule Prescription ORAL AB Nov 9, 1987


27. APPCO

Appco Pharma Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Appco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Prescription ORAL AB Apr 1, 2021
EQ 25MG BASE capsule Prescription ORAL AB Apr 1, 2021
EQ 10MG BASE capsule Prescription ORAL AB Apr 1, 2021
EQ 100MG BASE capsule Prescription ORAL AB Apr 1, 2021
EQ 75MG BASE capsule Prescription ORAL AB Apr 1, 2021


28. EDENBRIDGE PHARMS

Edenbridge Pharmaceuticals Llc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Edenbridge Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE capsule Prescription ORAL AB Apr 19, 2022


29. CONTRACT PHARMACAL

Contract Pharmacal Corp has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Contract Pharmacal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE capsule Prescription ORAL AB Jul 28, 2020
EQ 75MG BASE capsule Prescription ORAL AB Jul 28, 2020
EQ 10MG BASE capsule Prescription ORAL AB Jul 28, 2020
EQ 50MG BASE capsule Prescription ORAL AB Jul 28, 2020
EQ 100MG BASE capsule Prescription ORAL AB Jul 28, 2020


30. PAR PHARM

Par Pharmaceutical Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Par Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE capsule Discontinued ORAL N/A Nov 9, 1987
EQ 50MG BASE capsule Discontinued ORAL N/A Nov 9, 1987
EQ 75MG BASE capsule Discontinued ORAL N/A Nov 9, 1987
EQ 150MG BASE capsule Prescription ORAL N/A Nov 9, 1987
EQ 10MG BASE capsule Discontinued ORAL N/A Nov 9, 1987


31. TARO

Taro Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Prescription ORAL AB Jul 1, 2020
EQ 75MG BASE capsule Prescription ORAL AB Jul 1, 2020
EQ 50MG BASE capsule Prescription ORAL AB Jul 1, 2020
EQ 25MG BASE capsule Prescription ORAL AB Jul 1, 2020
EQ 10MG BASE capsule Prescription ORAL AB Jul 1, 2020


32. DAVA PHARMS INC

Dava Pharmaceuticals Inc has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Dava Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Discontinued ORAL N/A Jan 5, 1988
EQ 75MG BASE capsule Discontinued ORAL N/A Jan 5, 1988
EQ 25MG BASE capsule Discontinued ORAL N/A Jan 5, 1988
EQ 10MG BASE capsule Discontinued ORAL N/A Jan 5, 1988
EQ 150MG BASE capsule Discontinued ORAL N/A Jan 5, 1988
EQ 100MG BASE capsule Discontinued ORAL N/A Jan 5, 1988


33. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE tablet Prescription ORAL AB Jul 24, 2020
EQ 3MG BASE tablet Prescription ORAL AB Jul 24, 2020


34. JUBILANT CADISTA

Jubilant Cadista Pharmaceuticals Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Jubilant Cadista.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE capsule Prescription ORAL AB Mar 14, 2022
EQ 50MG BASE capsule Prescription ORAL AB Mar 14, 2022
EQ 25MG BASE capsule Prescription ORAL AB Mar 14, 2022
EQ 10MG BASE capsule Prescription ORAL AB Mar 14, 2022
EQ 100MG BASE capsule Prescription ORAL AB Mar 14, 2022


35. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Prescription ORAL AB Sep 4, 2020
EQ 50MG BASE capsule Prescription ORAL AB Sep 4, 2020
EQ 25MG BASE capsule Prescription ORAL AB Sep 4, 2020
EQ 10MG BASE capsule Prescription ORAL AB Sep 4, 2020
EQ 75MG BASE capsule Prescription ORAL AB Sep 4, 2020


36. SANDOZ

Sandoz Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE capsule Discontinued ORAL N/A May 15, 1986
EQ 25MG BASE capsule Discontinued ORAL N/A May 15, 1986
EQ 50MG BASE capsule Discontinued ORAL N/A May 15, 1986
EQ 10MG BASE capsule Discontinued ORAL N/A Mar 2, 1987
EQ 100MG BASE capsule Discontinued ORAL N/A Mar 2, 1987